EFFECT OF TOPICAL MITOMYCIN-C (0.01%) IN TREATMENT OF SEVERE VERNAL REFRACTORY KERATOCONJUNCTIVITIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EMAD S.M.H.; HAJI AHMADI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS) Year:2005 | Volume:7 | Issue:4 (28) Page(s): 44-47

Download Full-Text

Persian Verion

View:

1,158

Download:

Cites:

Information Journal Paper

Title

EFFECT OF TOPICAL MITOMYCIN-C (0.01%) IN TREATMENT OF SEVERE VERNAL REFRACTORY KERATOCONJUNCTIVITIS

Author(s)

EMAD S.M.H. | HAJI AHMADI M. | Issue Writer Certificate

Keywords

SEVERE VERNAL KERATOCONJUNCTIVITISQ3

COMPLICATIONQ4

MITOMYCIN - CQ3

Abstract

BACKGROUND AND OBJECTIVE: Severe cases of vernal keratoconjunctivitis can reduce visual acuity due to corneal involvement. This study was performed to evaluate the efficacy and safety of low- dose topical mitomycin- c in patients with SEVERE VERNAL KERATOCONJUNCTIVITIS refractory (SVKC) to conventional treatment. METHODS: This clinical trial was performed on 36 refractory cases of SVKC. All of the patients were using corticosteroid and mast cell stabilizer before they entered this study but their symptoms and signs were persistent.Topical MITOMYCIN - C 0.01% was used in both eyes of 18 patients for 14 days. The other patients (18 cases) were used saline normal drop. The symptoms and signs were checked on the day of enrollment and were compared at the end of first and second weeks. All of the patients were following up 4 week post treatment for required additional medication.FINDINGS: There was a significant decrease in all the symptoms and signs after 2 weeks of treatment. Only papillary reaction was persistent despite treatment in 14 cases. Drug toxicity was observed in two eyes manifesting as punctuate keratitis. None of the patients required any other medication during the 4 weeks post treatment.CONCLUSION: Short-term, low-dose mitomycin-c may be considered in the acute exacerbation periods of patients with SVKC refractory to conventional treatment.

Cites

No record.

References

Cite

APA: Copy

EMAD, S.M.H., & HAJI AHMADI, M.. (2005). EFFECT OF TOPICAL MITOMYCIN-C (0.01%) IN TREATMENT OF SEVERE VERNAL REFRACTORY KERATOCONJUNCTIVITIS. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), 7(4 (28)), 44-47. SID. https://sid.ir/paper/73151/en

Vancouver: Copy

EMAD S.M.H., HAJI AHMADI M.. EFFECT OF TOPICAL MITOMYCIN-C (0.01%) IN TREATMENT OF SEVERE VERNAL REFRACTORY KERATOCONJUNCTIVITIS. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS)[Internet]. 2005;7(4 (28)):44-47. Available from: https://sid.ir/paper/73151/en

IEEE: Copy

S.M.H. EMAD, and M. HAJI AHMADI, “EFFECT OF TOPICAL MITOMYCIN-C (0.01%) IN TREATMENT OF SEVERE VERNAL REFRACTORY KERATOCONJUNCTIVITIS,” JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), vol. 7, no. 4 (28), pp. 44–47, 2005, [Online]. Available: https://sid.ir/paper/73151/en

Related Journal Papers